書籍詳細

炎症リウマチ

P.7 掲載の参考文献

• 1) Sweet RD:An acute febrile neutrophilic dermatosis. Br J Dermatol 74:349-56, 1964

• 2) Clemmensen OJ, Menne T, Brandrup F, et al:Acute febrile neutrophilic dermatosis-a marker of malignancy. Acta Derm Venereol (Stockh) 69:52-8, 1989
  pubmed

• 3) Goette DK:Sweet's syndrome in subacute cutaneous lupus erythematosus. Arch Dermatol 121:789-91, 1985
  pubmed

• 4) Mizoguchi M, Chikakane K, Goh K, et al:Acute febrile neutrophilic dermatosis (Sweet's syndrome) in Behcet's disease. Br J Dermatol 116:727-34, 1987
  pubmed

• 5) Prystowsky SD, Fye KH, Goette KD, et al:Acute febrile neutrophilic dermatosis associated with sjogren syndrome. Arch Dermatol 114:1234-5, 1987

• 6) Kemmet D, Hunter JAA:Sweet's syndrome:a clinicopathological review of twenty-nine cases. J Am Acad Dermatol 23:503-7, 1990

• 7) Horio T, Danno K, Okamoto H, et al:Potassium iodide in erythema nodosum and other erythematous dermatoses. J Am Acad Dermatol 9:77-81, 1983
  pubmed

• 8) Driesch P:Sweet's syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 31:535-56, 1994
  pubmed

• 9) Trentham DE, Masi AT, Bale GF:Arthritis with an inflammatory dermatosis resembling Sweet's syndrome-report of a unique case and review of the literature on arthritis associated with inflammatory dermatoses. Am J Med 61:424-32, 1976
  pubmed

• 10) Nolla JM, Juanola X, Valverde J, et al:Arthritis in acute febrile neutrophilic dermatosis (Sweet's syndrome). Ann Rheum Dis 49:135, 1990
  pubmed

• 11) Harary AM:Sweet's syndrome associated with rheumatoid arthritis. Arch Intern Med 143:1993-5, 1983
  pubmed

• 12) Delaporte E, Gaveau DJ, Piette FA, et al:Acute febrile neutrophilic dermatosis (Sweet's syndrome)-association with rheumatoid vasculitis. Arch Dermatol 125:1101-4, 1989
  pubmed

• 13) Jorizzo JL, Daniels JC:Dermatologic conditions reported in patients with rheumatoid arthritis. J Am Acad Dermatol 8:439-57, 1983
  pubmed

• 14) Maekawa Y, Kageshita T, Nagata T:A case of acute febrile neutrophilic dermatosis (Sweet's syndrome-Ademonstration of IgM and C3 deposits on the vessel walls in involved skin. J Dermatol 11:560-4, 1984

P.14 掲載の参考文献

• 1) Moll JMH, Wright V:Psoriatic arthritis. Semin Arthritis Rheum 3:55-78, 1973

• 2) 橋本公二, 岡部紀和, 中田精三, ほか:乾癬性関節炎とHLA抗原. 日皮会誌89:695-698, 1979

• 3) 大城戸宗男, 小澤明, 原田照太郎:日本乾癬学会登録症例の集計-1991年度-. 第6回日本乾癬学会記録集, pp. 68-73, 1991

• 4) 大河原章, 北村清隆, 小林仁, ほか:汎発性膿庖性乾癬-第2, 3次全国調査における治療の検討-. 稀少難治性疾患調査研究班平成2年度研究報告書, pp. 11-15, 1991

P.20 掲載の参考文献

• 1) Ravault PP, Vignon G, Berthier L:Aux confins de la maladie Bouillaud:le rhumatisme articulaire subaigti de l'adulte. Rev Rhum 17:290-294, 1950

• 2) 七川歡次, 折原正美, 山本正, ほか:亜急性関節リウマチについて. 東京, 第5回リウマチ談話会, 昭和35年

• 3) Ravault PP, Vignon G, Robert JM:Le rhumatisme articulaire subaigu de l' adulte. Rev Rhum 25:354-374, 1958

• 4) Chevalier J:Rhumatisme articulaire subaigu curable, rhumatisme post-angineux, rhumatismes infectieux. Rev Rhum 30:204-212, 1963

• 5) 七川歡次, 前田晃, 辻本正記, ほか:亜急性関節リウマチについて. 臨床整形外科2:907-914, 昭和42年

• 6) 七川歡次, 広田茂永:非侵食性RA. リウマチ病セミナーIV (七川歡次, 監修), pp. 30-37, 大阪, 永井書店, 1993

• 7) Leu HJ:Die abortive polyarthritis rheumatica acuta. Praxis 43:913-91, 1954
  pubmed

• 8) Lawrence JS, Bennett PH:Benign polyarthritis. Ann Rheum Dis 19:200-30, 1960

• 9) Zeidler H, Hulsemann JL:Benign polyarthritis and undifferentiated arthritis. Scand J Rheumatol 79:13-20, 1984

• 10) Wolfe F, Ross K, Hawley J, et al:The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic:A study of 1141 patients, J Rheumatol 20:2995-2009, 1993

• 11) Nissila M, Isomaki HA, Karrella k, et al:Prognosis of inflammatory joint diseases:A three-year follow-up study. Scand J Rheumatol 12:33-38, 1983

• 12) O'Sulllivan JB, Cathcart ES:The prevalence of rheumatoid arthritis:Follow-up evaluation of the effect of criteria on rates in Sudbury, Massachusetts. Ann Intern Med 76:573-577, 1972

• 13) Pincus T, Callahan LF:How many types meet classification criteria for rheumatoid arthritis. J Rheumatol 21:1385-1369, 1994
  pubmed

• 14) 前田晃, 村田紀和:早期RA患者の予後調査. 第7回関西リウマチ学会総会, 1993

• 15) 村田紀和, 前田晃:早期RAの手. 足変形予防に対する長期研究 (第9報) -手のレ線変化とHLA-DR4. 1との相関, 平成4年度特定疾患調査研究報告書. 骨77-81, 1993

• 16) 前田晃, 村田紀和, 志水正敏, ほか:早期RAの手. 足の変形予防に対する長期研究, 平成5年度特定疾患調査研究報告書. 骨36-38, 1994

P.29 掲載の参考文献

• 1) Frankel AH, Singer DRJ, Winearls CG, et al:Type II essential mixed cryoglobulinaemia:Presentation, treatment and outcome in 13 patients. Quarterly J Med 298:101-124, 1992

• 2) Ponticelli C, et al:Essential mixed cryoglobulinemia. In:Disease of the Kidney (Ed, Schrier RW), pp. 2377-2392, Little Brown, Boston, 1988

• 3) 飯村康夫:クリオグロブリン. 日本臨牀47:107-110, 1989

• 4) Hunder GG, Arend WP, Bloch DA, et al:The american college of rheumatology 1990 criteria for the classification of vasculitis. Arthritis Rheum 33:1065-1136, 1990
  pubmed

• 5) D' Amico G:Renal involvement in essential mixed cryoglobulinemia. Kidney Int 35:1004, 1989
  pubmed

• 6) Toschi V, Fiorini GF, Motta A, et al:Structural and functional characterization of plasma fibronectin in patients with essential mixed cryoglobulinemia. Eur J Clin Chem Clin Biochem 30:473-479, 1992
  pubmed

• 7) Ferri C, La Civita L, Zignego AL, et al:Plasma levels of endothelin-1 in mixed cryoglobulinaemia patients (letter). Br J Rheumatol 33:689-690, 1994
  pubmed

• 8) Hundt M, Zielinska-Skowronek M, Schmidt RE:Fc r receptor activation of neutrophils in cryoglobulin-induced leukocytoclastic vasculitis. Arthritis Rheum 36:974-982, 1993
  pubmed

• 9) Cohen SJ, Pittelkow MR, Daniel Su WP:Cutaneous manifestations of cryoglobulinemia:clinical and histopathologic study of seventy-two patients. J Am Acad Dermatol 25:21-27, 1991

• 10) Ferri C, La Civita L, Cirafisi C, et al:Peripheral neuropathy in mixed cryoglobulinemia:clinical and electrophysiologic investigations. J Rheumatol 19:889-895, 1992

• 11) Gemignani F, Pavesi G, Fiocchi A, et al:Peripheral neuropathy in essential mixed cryoglobulinemia. JNeurol Neurosurg Psychiatry 55:116-120, 1992
  pubmed

• 12) Abel G, Zhang QX, Agnello V:Hepatitis C virus infection in type H mixed cryoglobulinemia. Arthritis Rheum 36:1341-1349, 1993

• 13) 森田 博, 梅本典江:肝炎ウイルスとリウマチ病. リウマチ病セミナーV (七川歡次, 監修), pp. 30-39, 大阪, 永井書店, 1994

• 14) Pascual M, Perrin L, Giostra E, et al:Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 162:569-570, 1990

• 15) Casato M, Pucillo LP, Lagana B, et al:Cryoglobulinemia and hepatitis C virus. Lancet 337:1047-1048, 1991
  pubmed

• 16) Ferri C, Greco F, Longombardo G, et al:Antibodies to hepatitis C virus in patients with mixedcryoglobulinemia. Arthritis Rheum 34:1606-1610, 1991

• 17) Misiani R, Bellavita P, Fenili D, et al:Hepatitis C virus infection in patients with essential mixedcryoglobulinemia. Ann Intern Med 117:573-577, 1992

• 18) Agnello V, Chung RT, Kaplan LM:A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327:1490-1495, 1992
  pubmed

• 19) Munoz-Fernandez S, Barbado FJ, Martin Mola E, et al:Evidence of hepatitis C virus antibodies in thecryoprecipitate of patients with mixed cryoglobulinemia. J Rheumatol 21:229-233, 1994
  pubmed

• 20) Ferri C, Longombardo G, La Civita L, et al:Hepatitis C virus chronic infection as a common cause of mixedcryoglobulinemia and autoimmune liver disease. J Intern Med 236:31-36, 1994

• 21) Cacoub P, Fabiani FL, Musset L, et al:Mixed cryoglobulinemia and hepatitis C virus. Am J Med 96:124-132, 1994

• 22) Lunel F, Musset L, Cacoub P, et al:Cryoglobulinemia in chronic liver diseases:role of hepatitis C virus and liver damage. Gastroenterology 106:1291-1300, 1994
  pubmed

• 23) Gabrielli A, Manzin A, Candela M, et al:Active hepatitis C virus infection in bone marrow and peripheralblood mononuclear cells from patients with mixed cryoglobulinemia. Clin Exp Immunol 97:87-93, 1994

• 24) 中尾尚之, 佐中攻:クリオグロブリン血症の治療. 日本臨牀50:312-316, 1992

• 25) Invernizzi F, Monti G:Colchicine and mixed cryoglobulinemia. Arthritis Rheum 36:722-723, 1993
  pubmed

• 26) Casato M, Lagana B, Antonelli G, et al:Long-term results of therapy with in terferon-a for type II essential mixed cryoglobulinemia. Blood 78:3142-3147, 1991

• 27) Ferri C, Marzo E, Longombardo G, et al:Interferon-a in mixed cryoglobulinemia patients:A randomized, crossover-controlled trial. Blood 81:1132-1136, 1993
  pubmed

• 28) Taillan B, Ferrari E, Garnier G, et al:Low-dose interferon alpha for mixed cryoglobulinemia associated with hepatitis C virus (letter). Am J Med 93:476, 1992
  pubmed

• 29) Misiani R, Bellavita P, Fenili D, et al:Interferon alfa-2 a therapy in cryoglobulinemia associated with hepatitis C virus. N Eng J Med 330:751-756, 1994

• 30) Durand JM, Cretel E, Kaplanski G, et al:Long-term results of therapy with interferon-α for cryoglobulinemia associated with hepatitis C virus infection. Clin Rheumatol 13:123-125, 1994

P.40 掲載の参考文献

• 1) Luft R, Ikkos D, Palmieri G, et al:A case of severe hyperthyroidism of nonthyroid origin with a defect in themaintenance of mitochondrial respiratory control:a correlated clinical, biochemical, and morphologicalstudy. Clin Invest 41:1776-1804, 1962

• 2) Engel WK, Cunningham GC:Papid examination of muscle tissue:a improved trichrome method for fresh frozen biopsy sections. Neurology 13:919-923, 1963

• 3) Shy GM, Gonatas NK:Human myopathy with giant abnormal mitochondria. Science 145:493-496, 1964
  pubmed

• 4) Shy GM, Gonatas NK, Perez M:Two childhood myopathy with abnormal mitochondrial. Megaconial myopathy. II. Pleoconial myopathy. Brain 89:133-158, 1966
  pubmed

• 5) Shapira Y, Harel S, Russel A:Mitochondrial encephalomyopathies. a group of neuromuscular disorderswith defects in oxidative metabolism. Isr J Neurol Sci 13:161-164, 1977

• 6) Holt IJ, Harding AE, Morgan-Hughes JA:Deletions of muscle mitochondrial DNA in patients withmitochondrial myopathies. Nature 331:717-719, 1988
  pubmed

• 7) Wallace DC, Singh G, Lott MT, et al:Mitochondrial DNA mutation associated with Leber's hereditary opticneuropathy. Science 242:1427-1430, 1988

• 8) 曽我文久, 上野聡, 依藤史郎:Kearns-Sayre症候群における異常ミトコンドリアDNAの解析. 日本臨牀51:2386-2390, 1993

• 9) Schon EA, Rizzuto A, Moraes H, et al:A direct repeat is a hotspot for large scale deletion of human mitochondrial DNA. Science 244:346-349, 1989

• 10) Moraes CT, Dimauro M, Zeviani A, et al:Mitochondrial DNA deletions in progessive external ophthalomoplegia and Kearns-Sayre syndrome. N Engl J M 320:1293-1299, 1989

• 11) Hayashi J, Ohta S, Takai D, et al:Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc Natl Acad Sci USA 88:10614-10618, 1991

• 12) Nakase H, Moraes, R, Rizzuto A, et al:Transcription and translation of deleted mitochondria genomes in Kearns-Sayre syndrome:implications for pathogenesis. Am J Hum Genet 46:418-427, 1990

• 13) Sakuta R, Nonaka I:Vascular involvement in mitochondrial myopathy. Ann Neurol 25:594-601, 1989
  pubmed

• 14) Kobayashi M, Morishita N, Sugiyama K, et al:Two cases of NADH-coenzyme Q reductase deficiency:relationship to MELAS syndrome. J Pediatr 110:223-227, 1987

• 15) Nishizawa M, Tanaka K, Shinozawa K, et al:A mitochondrial enchephalomyopathy with cardiomyopathy:a case revealing a defect of complex I of the respiratory chain. J Neurol Sci 78:189-201, 1987
  pubmed

• 16) Goto Y, Nonaka I, Horai S:A mutation in the tRNALeu (UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348:651-653, 1990
  pubmed

• 17) Kobayashi Y, Momoi MY, Tominaga K, et al:A point mutation in the mitochondrial tRNALeu (UUR) gene in MELAS. Biochem Biophys Res Commun 173:816-822, 1990
  pubmed

• 18) Fukuhara N, et al:Myoclonus epilepsy associated with ragged-red fibers (mitochondrial abnormalities):disease entity or a syndrome? Light and electron microscopic studies of two cases and review of literature. J Neurol Sci 47:117-133, 1980

• 19) Shoffner JM, Lott MT, et al:Myoclonic epilepsy and ragged-red fibers disease (MERFF) is associated with a mitochondrial DNA tRNALys mutation. Cell 61:931-937, 1990

P.44 掲載の参考文献

• 1) Bondi EE, Lazanls GS:Disorders of subcutaneous tissue, In Dermatology in General Medicine Vol I (Ed, Fitzpatrick TB, et al), pp. 1329-1344, New York, McGraw-Hill, 1993

• 2) Kaposi M:Pathologie und Therapie der Hautkrankheiten. Second Edition (Ed, Vienna, Urban and Schwarzenberg), p. 642, 1883 (文献4より引用)

• 3) Irgang S:Lupus erythematosus profundus. Arch Dermatol Syph 42:97-108, 1940 (文献4より引用)

• 4) Peters MS, Su WPD:Lupus erythematosus panniculitis. Med Clin North Amer 73:1113-1126, 1989

• 5) 杉浦勝己, 谷守, 撫養宗信, 磯ノ上正明, 田邉昇, 本多朋仁, 小塚雄民:シェーグレン症候群に伴うlupus erythematosus profundusの1例. 皮膚36:634-640, 1994

• 6) Tuffanelli DL:Lupus erythematosus panniculitis (profundus). Arch Dermatol 103:231, 1971
  pubmed

• 7) Dubois EL (Ed):Lupus erythematosus:A review of the current status of discoid and systemic lupus erythematosus and their variants, Ed 2. pp. 232-379, Los Angels, University of Southern California Press, 1974

• 8) Diaz-Jouanen E, DeHoratius RJ, Alarcon-Segovia D, et al:Systemic lupus erythematosus presenting as panniculitis (lupus profundus). Ann Intern Med 82:376, 1975

• 9) Kind P, Goerz G:Klinik und differentialdiagnose des cutanen lupus erythematodes. Z Hautkr 62:1337, 1987
  pubmed

P.50 掲載の参考文献

• 1) Sharp J, Purser DW:Spontaneous atlanto-axial dislocation in ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis 20:47-77, 1961
  pubmed

• 2) Hamilton MG, MacRae ME:Atlantoaxial dislocation as the presenting symptom of ankylosing spondylitis. Spine 18:2344-2346, 1993
  pubmed

• 3) Etude critique des complications radiculomedullaires et neuro-musculaires de la spondylarthrite ankylosante. Revue du Rhumatisme 54:221-227, 1987

• 4) Peh WCG, Luk KD:Pseudoarthrosis in ankylosing spondylitis. Ann Rheum Dis 53:206-210, 1994

• 5) Weinstein PR, Karpman RR, Gall EP, et al:Spinal cord injury, spinal fracture and spinal stenosis in ankylosing spondylitis. J Neurosurg 57:609-616, 1982
  pubmed

• 6) Kiwerski J:Hyperextension-dislocation injuries of the cervical spine. Injury 24:674-677, 1993
  pubmed

• 7) Graham B, Van Peteghem PK:Fracture of the spine in ankylosing spondylitis. Spine 14:803-807, 1989
  pubmed

• 8) Bowie EA, Glasgow GL:Cauda equina lesions associated with ankylosing spondylitis. Br Med J 2:24-27, 1961
  pubmed

• 9) Thomas DJ, Kendall MJ, Whitfield AGW:Nervous system involvement in ankylosing spondylitis. Br Med J 26:148-150, 1974

• 10) Bartleson JD, Cohen MD, Harrington TM, et al:Cauda equina syndrome secondary to longstanding ankylosing spondylitis. Ann Neurol 14:662-669, 1983
  pubmed

• 11) Normand Jp, Dufour M, Lang JY, et al:Radiographic feature of cauda equina syndrome complicatingankylosing spondylitis. Canad Asso Radiol J 45:58-61, 1994

• 12) Shaw PJ, Allcutt DA, Bates D, et al:Cauda equina syndrome associated with multiple lumber arachnoidcysts in ankylosing spondylitis:Improvement following surgical therapy. J Neurol Neurosurg Psychiatry 53:1076-1079, 1990

• 13) Okada S, Hase H, Hirasawa Y, et al:A case report of lumboperitoneal shunt for cauda equina syndrome in ankylosing spondylitis. Spine 17:59-61, 1991

P.57 掲載の参考文献

• 1) 大藤真, ほか:シェーグレン症候群の病型分類:厚生省特定疾患シェーグレン病調査研究班, 昭和52年度研究業績報告, pp. 3-6, 1978

• 2) Pokorny G, Nemeth J, Marczinovits I, et al:Primary Sjogren's syndrome from the viewpoint of an internal physician. International Ophthal 15:401-406, 1991

• 3) Gilula LA, Bliznak J, Staple TW:Idiopathic nonfamilial acro-osteolysis with cortical defects and mandibular ramus osteolysis. Radiology 121:63-68, 1976
  pubmed

• 4) Golstein MA, Durez P, Andrien M, et al:A propos de l'association rare entre spondylarthropathie et synrome de Gougerot-Sjogren. Rev Rhum 60:658, 1993

• 5) 梅木健一, 行岡正雄, 七川歡次, 仲谷吉記:Sjogren syndromeを伴ったacro osteolysisの1例. 第300回整形外科集談会阪神地方会, 平成6年6月18日発表

• 6) 武仲善孝:シェーグレン症候群を伴う脊椎炎の3例. 第33回三重リウマチ膠原病研究会, 1994

P.64 掲載の参考文献

• 1) Healey LA, Sheets PK, et al:The relation of polymyalgia rheumatica to rheumatoid arthritis. J Rheumatol 15:750-752, 1989

• 2) Robbins DL, White RH:Interrelationship between polymyalgia rheumatica and polyarthritis. J Rheumatol 15:1323-1325, 1988
  pubmed

• 3) Kyle V, Tudor J, et al:Parity of synovitis in polymyalgia rheumatica. Ann Rheum Dis 49:155-157, 1990

• 4) Hantzschel H, Bird HA, et al:Polymyalgia rheumatica and rheumatoid arthritis of the elderly. a clinical, laboratory, and scintigraphic comparison. Ann Rheum Dis 50:619-622, 1991
  pubmed

• 5) Kyle V:Laboratory investigations including liver in polymyalgia rheumatica/giant cell arteritis. Bailliere's Clin Rheumatol 5:475-484, 1991

• 6) Macchioni P, Boiardi L, Salvarani C, et al:Lymphocyte subpopulation analysis in peripheral blood inpolymyalgia rheumatica/giant cell arteritis. Br J Rheumatol 32:666-670, 1993
  pubmed

• 7) Cimmino MA:A seasonal pattern in the onset of polymyalgia rheumatica. Ann Rheum Dis 49:521-523, 1990
  pubmed

• 8) Nordborg E, Anderson R, Tengborn L, et al:Von Willbrand factor antigen and plasminogen activator inhibitor in giant cell arteritis. Ann Rheum Dis 58:316-328, 1991

• 9) Uddhammar S, Rantapaa-Dahlqvist S, Nilsson TK:Plasminogen activator inhibitor and von Willebrand factor in polymyalgia rheumatica. Clinical Rheumatol 11:211-215, 1992

• 10) Pawlowski T, Aeschlimann A, Kahn MF, et al:Microheterogeneity of acute phase proteins in the differentiation of polymyalgia rheumatica from polymyositis. J Rheumatol 17:1187-1192, 1990
  pubmed

• 11) Dasgupta B, Panayi GS:Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cellarteritis. Br J Rheumatol 29:456-458, 1990
  pubmed

• 12) Roche NE, Fulbright JW, Wagner AD, et al:Correlation of interleukin-6 production and disease activity inpolymyalgia rheumatica and giant cell arteritis. Arthritis Rheumat 16:1286-1294, 1993

• 13) Salvarani C, Macchioni P, Boiard L, et al:Solble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. clinical and laboratory correlations. J Rheumatol 19:1100-1106, 1992

• 14) Kyle V, Hazleman BL:Stopping steroids in polymyalgia rheumatica and giant cell arteritis. treatment usually lasts for two to five years. Br Med J 300:344-345, 1990

P.73 掲載の参考文献

• 1) 厚生省, 特定疾患治療研究医療受給者調査報告書, 1990

• 2) Fitzgerald AA, Davis P:Arthritis, hilar adenopathy, erythema nodosum complex. J Rheumatol 9:935-938, 1982
  pubmed

• 3) Delaney P:Meurologic manifestations in sarcoidosis. Review of the literature, with a report of 23 cases. Ann Intern Med 87:336-345, 1977

• 4) 山下真木夫, 安田斎, 園部正信, ほか:興味あるMRI像を呈した脊髄サルコイドーシスの1例. 臨床神経31:734-737, 1991

• 5) Williams RC:Rheumatoid arthritis as a systemic disease. Major Probl Intem Med 4:1, 1974

• 6) Hughes JT:Spinal cord involvement by C4-5 vertebral subluxation in rheumatoid arthritis. A description of 2 cases examined at necropsy. Ann Neurol 1:575-582, 1977

• 7) Marted W, Abell MR:Fatal atlanto-axial luxation in rheumatoid arthritis. Arthritis Rheum 6:224-231, 1963

• 8) Matthews WB:Sarcoid neuropathy. In:Peripheral Neuropathy (Ed, Dyck PJ, et al), pp. 1418-1419, Philadelphia, WB Saunders, 1993

• 9) Kaplan H:Sarcoid arthritis:a review. Arch Int Med 112:929-935, 1963

• 10) Mitchell DN:Sarcoidosis with skeletal involvement. In:Rheumatology (Ed, Klippel JH, et al), pp. 3, 37. 1-37. 8, London, Mosby, 1994

• 11) Spilberg I, Siltzbach LE, McEwen C:The arthritis of sarcoidosis. Arthritis Rheum 12:126-137, 1969
  pubmed

• 12) Benatar SR:Sarcoidosis in south Africa. S Afr Med J 52:602-606, 1936

• 13) Mayock RL, et al:Manifestations of sarcoidosis, analysis of 145 patients, with review of 9 series selected from literature. Am J Med 35:67-89, 1963

• 14) 斉藤潤, 井上康二, 小宮靖弘, ほか:関節症状を呈したサルコイドーシスの一例. 整形外科43:971-973, 1992

• 15) Stijernberg N, et al:Muscle involvement insarcoidosis. Acta Med Scand 209:213-216, 1981

• 16) Israel HL, Sones M:Selection of biopsy procedures for sarcoidosis diagnosis. Arch Intern Med 113:255-260, 1964
  pubmed

• 17) 上古真理, 安田斎, 寺田雅彦, ほか:頻回に眼筋麻痺を繰り返したサルコイドーシスの1例. 臨床神経34:882-885, 1994

• 18) Schumacher HR:Sarcoidosis. In:Arthritis and Allied Conditions (Ed, McCarty DJ), pp. 1294-1300, Philadelphia, Lea & Febriger, 1989

骨関節, 脊椎, 神経

P.85 掲載の参考文献

• 1) 鈴江緑衣郎, 小林正, 糸川嘉則:食品とビタミン. ビタミンと栄養 (日本ビタミン学会編), pp. 37-58, 京都, 化学同人, 1990

• 2) 平成5年版国民栄養の現状:厚生省保健医療局健康増進栄養課監修

• 3) Farris WA, Erdman JW:Protracted hypervitaminosis A followiinglong-term low-level intake. JAMA 247:1317-1318, 1982
  pubmed

• 4) 糸川嘉則:ビタミンの欠乏症と過剰症. ビタミンと栄養 (日本ビタミン学会編), pp. 73-76. 京都, 化学同人, 1990

• 5) Silverman AK, Charles NE, Voorhees JJ, et al:Hypervitaminosis A syndrome:A paradigm of retinoid side effects. J Am Acad Dermatol 16:1027-1039, 1987

• 6) Milstone LM, McGuire J, Ablow RC:Premature epiphyseal closure in a child receiving oral 13-cis-retinoic acid. J Am Acad Dermatol 7:663-666, 1982

• 7) Prendiville J, Bingham EA, Burrrows D:Premature epiphyseal closure-a complication of etretinate therapy in children. J Am Acad Dermatol 15:1259-1262, 1986

• 8) DiGiovanna JJ, Helfgott RK, Gerber LH, et al:Extraspinal tendon and ligament calcification associated with long-term therapy with etretinate. N Eng J Med 315:1177-1182, 1986

• 9) Smith R, Triffitt JT:Bones in muscles:The problem of soft tissue ossification. Q J Med 61:985-990, 1986
  pubmed

• 10) Novick NL, Lawson W, Schwartz IS:Bilateral nasal bone osteophytosis associated with short-term oral isotretinoin therapy for cystic acne vulgaris. Am J Med 77:736-739, 1984
  pubmed

• 11) Tfelt-Hansen P, Knudsen B, Petersen E, et al:Spinal cord compression after long-term etretinate. Lancet ii:325-326, 1989

• 12) Thomas BJ, Amstutz HC:Results of the administration of diphosphonate for the prevention of heterotopic ossification after total hip arthroplasty. J Bone Joint Surg 67-A:400-403, 1985
  pubmed

• 13) Gown AM:The mysteries of the myofibroblast (partially) unmasked. Lab Invest 63:1-3, 1990
  pubmed

• 14) Povysil C, Matejovsky Z:Ultrastructural evidence of myofibroblasts in pseudomalignant myositis ossificans. Virchows Arch A Pathol Anat Histol 381:189-203, 1979
  pubmed

• 15) Illes T, Dubousset J, Szendroi M, et al:Characterization of bone forming cells in posttraumatic myositis ossificans by lectins. Path Res Pract 188:172-176, 1992
  pubmed

• 16) Bioulac-Sage P, Quinton A, Saric J, et al:Chance discovery of hepatic fibrosis in patient with asymptomatic hypervitaminosis A. Arch Pathol Lab Med 112:505-509, 1988
  pubmed

• 17) Abiteboul M, Arlet J, Sarrabay MA, et al:Metabolism of. vitamin A in Forestier-Rotes-Queral hyperostosis. Rev Rhum Mal Osteoartic 53:143-145, 1986

• 18) Dougados M, Leporho MA, Esmilaire L, et al:Plasma levels of vitamin A and E in hyperostosis, ankylosing spondylarthritis and rheumatoid polyarthritis. Rev Rhum Mal Osteoartic 55:251-254, 1988

• 19) Periquet B, Lambert W, Garcia J, et al:Increased concentrations of endogenous 13-cis-and all-trans-retinoic acids in diffuse idiopathic skeletal hyperostosis, as demonstrated by HPLC. Clin Chim Acta 203:57-65, 1991
  pubmed

• 20) 武者芳郎:脊柱靭帯骨化の成因に関する研究:患者の食品摂取傾向と性ホルモンについて. 日整会誌64:1059-1071, 1990

• 21) Inoue K, Imai S, Iwasaki A, et al:Etretinate-induced heterotopic bone formation about the hip joint:a case report including ultrastructural study. Clin Orthop 308:139-145, 1994
  pubmed

P.94 掲載の参考文献

• 1) Huber-Levernieux Cl:Pathologie articulaire et Periarticulaire de l'interligne de Lisfranc. In. L'Actualite' Rhumatologique 1991 (Ed, de Seze S, et al), pp.105-114, Paris, Expansion Scientifique, 1991

• 2) Jahss MH:Disorders of the foot. pp.1-138 WB Saunders Company, 1982

• 3) Helfet AJ, Gruebel Lee DM:Disorders of the foot. pp.1-30 JB Lippincott Company, 1980

• 4) Cailliet R, (荻島 秀男, 訳):足と足関節の痛み. 原著第2版, pp.1-48 医歯薬出版, 1987

• 5) Arntz CT, Veith RG, Hansen ST, et al:Fractures and fracture-dislocations of the tarsometatarsal joint. J Bone Joint Surg 70-A:173-181, 1988
  pubmed

• 6) Minaker K, Little H:Painful feet in rheumatoid arthritis. Can Med Assoc J 109:724-730, 1973
  pubmed

• 7) Bouysset M, Tebib J, Noel E, et al:Rheumatoid metatarsus. The original evolution of the first metatarsal. Clin Rheumatol 10:408-412, 1991
  pubmed

• 8) Claustre J, Bonnel F, Simon L:La rhizarthose podale. Rev Rhum 56:539-543, 1989

• 9) Dhillon MS, Sharma S, Gill SS, et al:Tuberculosis of bones and joints of the foot:An analysis of 22 cases. Foot Ankle 14:505-513, 1993
  pubmed

• 10) Cavanagh PR, Vickers KL, Young MJ, et al:Radiographic abnormalities in the foot of patients with diabetic neuropathy. Diabetic Care 17:201-209, 1994
  pubmed

• 11) Selby PL, Young MJ, Boulton AMJ:Bisphosphonates:A new treatment for diabetic Charcot neuropathy? Diabetic Med 11:28-31, 1994

P.100 掲載の参考文献

• 1) Biebuyck JC, Katz LD, McCauley T:Soft tissue edema in osteoid osteoma. Skeletal Radiol 22:37-41, 1993
  pubmed

• 2) Graham HK, Laverick MD, Cosgrove AP, et al:Minimally invasive surgery for osteoid osteoma of the proximal femur. J Bone Joint Surg 75-B:115-118, 1993

• 3) Healey JH, Ghelman B:Osteoid osteoma and osteoblastoma. Current concepts and recent advances. Clin Orthop 204:76-85, 1986
  pubmed

• 4) Klein MH, Shankman S:Osteoid osteoma:radiologic and pathologic correlation. Skeletal Radiol 21:23-31, 1992
  pubmed

• 5) Kneisl JS, Simon MA:Medical management compared with operative treatment for osteoid-osteoma. J Bone Joint Surg 74-A:179-85, 1992
  pubmed

• 6) Makley JT, Dunn MJ:Prostaglandin synthesis by osteoid osteoma. Lancet 2:42, 1982
  pubmed

• 7) Mirra JM, Picci P, Gold RH:Bone tumors. Clinical, radiologic, and pathloic correlations. Philadelphia, Lea and Febiger, 1989

• 8) Saville PD:A medical option for the treatment of osteoid osteoma. Arthritis Rheum 23:1409-10, 1980
  pubmed

• 9) Schulman L, Dorfman HD:Nerve fibers in osteoid osteoma. J Bone Joint Surg 54-A:1351-56, 1970

• 10) Ward WG, Eckardt JJ, Shayestehfar S, et al:Osteoid osteoma diagnosis and management with low morbidity. Clin Orthop 291:229-35, 1993
  pubmed

• 11) Wold LE, Pritchard DJ, Bergert J, et al:Prostagalandin synthesis by osteoid osteoma and osteoblastoma. Mod Pathol 1:129-131, 1988

P.117 掲載の参考文献

• 1) 広瀬哲司, 片岡治, 庄智矢, ほか:小児と若年者の腰痛疾患の臨床的解析. 中部整災誌 33:169-172, 1990

• 2) 佃政憲, 鷲見正敏, 片岡治, ほか:若年性腰椎椎間板ヘルニア. 臨整外 28:513-518, 1993

• 3) King H:Back pain in children. In:The pediatric apine:principles and practice. (Ed, Weinstein SL), pp.173-183, New York, Raven Press, 1994

• 4) Loder RT, Hensinger RN:Developmental abnormalities of the cervical spine. ibid, pp.397-420

• 5) 村瀬正昭, 井形高明:スポーツによる成長期腰椎椎体終板の障害. 臨床スポーツ医学 7:187-190, 1990

• 6) Bradford DS:Juvenile kyphosis. In:Moe's textbook of scoliosis and other spinal defomities. 3rd ed (Ed, Lonstein JE, et al), pp.349-367, Philadelphia, Saunders, 1995

• 7) Ascani E, LaRosa G:Scheuermann's kyphosis. In:The pediatric spine:principles and practice (Ed, Weinstein SL), pp.557-584, New York, Raven Press, 1994

• 8) Resnick D:Osteochondroses. In:Diagnosis of bone and joint disorders (Ed, Resnick D), pp.3559-3610, Philadelphia, Saunders, 1995

• 9) Bluestone R, ed:Seronegative spondyloarthropathies. Clin Orthop 143:2-89, 1979

• 10) Calin A, ed:Spondyloarthropathies. pp.1-423, Orland, Grune & Stratton, 1984

• 11) Panayi GS, ed:Seronegative spondyloarthropathies. Clinics in Rheumatic Disease 11:1-173, 1985

• 12) 七川歡次:Enthesopathy. リウマチ学 (塩川優一, 編), pp.785-795, 東京, 同文書院, 1989

• 13) Agarwal A:Pre-ankylosing spondylitis. In:Ankylosing spondylitis (Ed, Moll JMH), pp.69-75, Edinburgh, Churchill Livingstone, 1980

• 14) Ansell BM:Juvenile spondylitis and related disorders. ibid, pp.120-136

• 15) Moll JMH:Diagnostic criteria and their evaluation. ibid, pp.137-150

• 16) Dixon AStJ, Macleod M:Diagnostic problems and differential diagnosis. ibid, pp.151-162

• 17) Tucker LB, Miller LC, Schaller JG:Rheumatic diseases. In:The pediatric apine:principles and practice. (Ed, Weinstein SL), pp.851-869, New York, Raven Press, 1994

• 18) 武仲善孝:Undifferentiated spondyloarthropathy. リウマチ病セミナーIII (七川歡次, 監修), pp.36-44, 大阪, 永井書店, 1992

• 19) 東村隆, 野原裕, 石川宏貴, ほか:硬膜外へ脱出した腰椎椎間板ヘルニアの運命. 臨整外 29:413-421, 1994

• 20) 中村孝文, 池田天史, 千田治道, ほか:脱出椎間板の自然吸収と臨床的意義. ibid:465-469, 1994

• 21) Kling Jr TF:Herniated nucleus pulposus and slipped vertebral apophysis. In:The pediatric spine:principles and practice. (Ed, Weinstein SL), pp.603-618, New York, Raven Press, 1994

• 22) Hamashima C, Kawabata T, Yosii T, et al:Schmorl's node on magnetic resonance imaging. Spine 19:450-453, 1994

• 23) 松井寿夫:家族歴と椎間板ヘルニア発症のリスク. MB Orthop '93増刊:135-140, 1993

• 24) Balague F, Skovron M-L, Nordin M, et al:Low back pain in schoolchildren. Spine 20:1265-1270, 1995
  pubmed

• 25) Nachemson AL:The natural course of low back pain. In:American Academy of Orthopaedic Surgeons. Symposium on idiopathic low back pain. (Ed, White III AA, Gordon SL), pp.46-51, St Louis, Mosby, 1982

• 26) Resnick D, Niwayama G:Degenerative disease of the spine. In:Diagnosis of bone and joint disorders. (Ed, Resnick D) 3 rd ed, pp.1372-1462, Philadelphia, Saunders, 1995

• 27) Kramer J:Pathological anatomy and pathophysiology. In:Intervertebral disk diseases. 2nd ed (translated by Mueller KH), pp.32-40, Stuttgart, Georg Thieme Verlag, 1990

• 28) 吉田宗人, 玉置哲也, 岩橋俊幸, ほか:MRIによる幼少年期における腰痛の診断とその治療経過. 中部整災誌 37:927-928, 1994

• 29) VanLinthoudt D, Revel M:Similar radiologic lesions of localized Scheuermann's disease of the lumbar spine in twin sisters. Spine 19:987-989, 1994

• 30) 片岡治, 栗原章, 編:腰仙部に皮膚陥凹を有し腰・下肢痛を訴えるtethered cord syndorme. 脊椎外科, pp.334-337, 東京, 南江堂, 1990

• 31) 真鍋英喜, 馬場逸志, 石田了久, ほか:Tethered cord syndrome 13例の治療経験中部整災誌 37:697-698, 1994

• 32) 西林保朗:Piriformis syndrome. リウマチ病セミナーII (七川歡次, 監修), pp.117-136, 大阪, 永井書店, 1991

• 33) Ogden JA, Ganey TM, Sasse J, et al:Development and maturation of the axial skeleton. In:The pediatric spine:principles and practice. (Ed, Weinstein SL), pp.3-69, New York, Raven Press, 1994

• 34) 武仲善孝, 福田真輔, 西林保朗, ほか:小児頸椎椎間板石灰化症について. 中部整災誌 23:1706-1707, 1980

P.124 掲載の参考文献

• 1) Heberden W:Commentaries on History and Cure of Diseases. (Payne T), pp. 148-149, London, 1802

• 2) Haygarth J:A Clinical History of Diseases. (Cadell and Davies), pp. 147-168, London, 1805

• 3) Adams R:A Treatise on Rheumatic Gout. London, John Churchill, 1857

• 4) Kellgren JH, Moore R:Generalized osteoarthritis and Heberden's nodes. Br Med J 1:181-187, 1952

• 5) Altman R, Asch E, Bloch D, et al:Development of criteria for the classification and reporting of osteoarthritis-Classification of osteoarthritis of the knee. Arthritis Rheum 29:1039-1049, 1986
  pubmed

• 6) Altman RD:The classification of osteoarthritis. J Rheumatol 22 (suppl 43):42-43, 1995

• 7) Crain DC:Interphalangeal osteoarthritis characterized by painful, inflammatory episodes, resulting in deformity of the proximal and distal articulations. JAMA 175:1949-1953, 1961

• 8) Peter JB, Pearson CM, Marmor L:Erosive osteoarthritis of the hands. Arthritis Rheum 9:365-388, 1966
  pubmed

• 9) Stecher RM:Heberden's nodes:A clinical description of osteoarthritis of the finger joints. Ann Rheum Dis 14:1-10, 1955

• 10) McKusick V:Genetic factors in disease of connective tissue:A survey of the present state of knowledge. Am J Med 2:283-302, 1959
  pubmed

• 11) Solomon L, Beighton P, Lawrence JW:Osteoarthrosis in a rural South African Negro population. Ann Rheum Dis 35:274-278, 1976

• 12) Kellgren JH, Lawrence JS, Bier F:Genetic factors in generalized osteoarthrosis, Ann Rheum Dis 22:237-255, 1963
  pubmed

• 13) 吉野良平:骨関節症のリスクファクター. リウマチ病セミナーI (七川歡次, 監修), pp. 157-170, 大阪, 永井書店, 1990

• 14) Ala-Kokko L, Baldwin CT, Moskowitz RW, et al:Single base mutation in the type II procollagen gene (COL2A1) as a cause of primary osteoarthritis associated with a mild chondrodysplasia. Proc Natl Acad Sci USA 87:6565-6568, 1990
  pubmed

• 15) Pun YL, Moskowitz RW, Lie S, et al:Clinical correlation of osteoarthritis associated with a single-base mutation (arginine519 to cysteine) in type II procollagen gene. Arthritis Rheum 37:264-269, 1994
  pubmed

• 16) Williams CJ, Considine EL, Knowlton RG, et al:Spondyloepiphyseal dysplasia and precocious osteoarthritis in a family with an Arg75-Cys mutation in the procollagen type II gene (COL2A1). Hum Genet 92:499-505, 1993

• 17) Bleasel JF, Bisagni-Faure A, Holderbaum D, et al:Type II procollagen gene (COL2A1) mutation in exon 11 associated with spondyloepiphyseal dysplasia, tall stature and precocious osteoarthritis. J Rheumatol 22:255-261, 1995
  pubmed

• 18) Ritvaniemi R, Korkko J, Bonaventure J, et al:Identification of COL2A1 gene mutations in patients with chondrodysplasias and familial osteoarthritis. Arthritis Rheum 38:999-1004, 1995

P.132 掲載の参考文献

• 1) 游逸明, 山本逸雄, 大中恭夫, ほか:DEXA法による全身骨塩量と組織量の測定の臨床的有用性について. 日骨形態誌 2:149-153, 1992

• 2) 游逸明, 山本逸雄, 大中恭夫, ほか:SXA法による踵骨骨密度測定の臨床的有用性について. 日骨形態誌 3:127-131, 1993

• 3) 游逸明, 山本逸雄, 大中恭夫, ほか:腰椎骨塩量測定と脊椎骨折閾値. 日医放学誌 52:217-222, 1992

• 4) 川口秀典, 岩崎和幸, 大谷正光, ほか:スポーツ女性と腰椎骨塩量.日骨代謝誌 9:299, 1991

• 5) 松本高明, 林泰史, 中嶋寛之, ほか:大学生柔道選手の体重と部位別骨量の関係. 日骨代謝誌 9:221, 1991

• 6) 渡辺基, 串田一博, 傅田正史, ほか:実業団サッカー選手及び陸上長距離選手の骨密度の検討 (運動の種類の相違による検討). 日骨代謝誌 9:223, 1991

• 7) 小池達也, 佐藤哲也, 朴一男, ほか:運動による骨量改善には瞬発力強化が, 持続力強化より優れている. 日骨代謝誌 9:224, 1991

• 8) Tsukahara N, Toda A, Goto J, et al:Cross-sectional nad longitudinal studies on the effect of water exercise in controlling bone loss in Japanese postmenopausal women. J Nuter Sci Vitaminol Tokyo 40:37-47, 1994

• 9) Bassey EJ, Ramsdale SJ:Increase in femoral bone density in young women following high-impact exercise. Osteoporos Int 4:72-5, 1994
  pubmed

• 10) 鳥居俊, 林泰史:女子長距離ランナーの骨塩量と内分泌ホルモンの関係. 日骨代謝誌 10:391, 1992

• 11) Constantini NW, Warren MP:Special problems of the female athlete. Baillieres Clin Rheymatol 8:199-219, 1994
  pubmed

• 12) Young N, Formica C, Szmukler G, Seeman E:Bone density at weightbearing and nonweight-bearing sites in ballet dancers:the effects of exercise, hypogonadism, and body weight. J Clin Endocrinol Metab 78:449-54, 1994
  pubmed

• 13) Kritz SD, Barrett CE:Grip strength and bone mineral density in older women. J Bone Miner Res 9:45-51, 1994

• 14) 清宮由美子, 陳瑞東, 平井康夫, ほか:初潮年令は最大骨量の決定因子である. 日骨代謝誌 11:274, 1993

• 15) Chesnut C3:Bone mass and exercise. Am J Med 95:1993

• 16) Rooney EM:Exercise for older patients:why it's worth your effort. Geriatrics 48:71-4, 1993

P.139 掲載の参考文献

• 1) Coffey RJ:The surgical treatment of primary hyperpathyroidism:A 20 year experiance. Ann Surg 15:518-523, 1977

• 2) Heath H, Hodgson SF, Kennedy MA:Primary hyperparathyroidism:incidence, morbidity, and potential economic impact in a community. N Eng L Med 302:189-193, 1980

• 3) 藤本吉秀:副甲状腺機能亢進症. 最新内科学体系 (井村裕夫ら, 編集), pp.62-79, 東京, 中山書店, 1993

• 4) 富田明夫:カルシウムとリンの異常. 内科学の展望-電解質異常. 日内会誌 74:720, 1985

• 5) Thompson NW, Eckhauser FE, Harness JK:The anatomy of primary hyperparathyroidism. Surgery 92:814-821, 1982
  pubmed

• 6) 石田常博, 横江隆夫, 泉雄勝:上皮小体腫瘍の全国集計 (1980年-1989年度症例). 内分泌外科 8:37-45, 1991

• 7) Scholz DA, Purnell DC:A symptomatic primary hyperparathyroidism. 10-year prospective study. Mayo Clinic Proceedings 56:473-478, 1981

• 8) 吉岡俊昭, 山口聖司, 宇都宮正登, ほか:原発性上皮小体機能亢進症:手術適応と手術手技における諸問題. 泌尿紀要 37:1185-1190, 1991

• 9) Abugassa S, Nordenstrom J, Eriksson S, et al:Skeletal remineralization after surgery for primary and secondary hyperparathyroidism. Surgery 107:128-133, 1990
  pubmed

• 10) Wilson RJ, Rao S, Ellis B, et al:Mild asymptomatic primary hyperparathyroidisum is not a risk factor for vertebral fractures. Ann Int Med 109:959-962, 1988

• 11) Alhava EM, Karjalainen P, Paakkonen M:Bone mineral density and surgical treatment of primary hyperparathyroidism. Act Chir Scand 154:345-347, 1988

• 12) Martin P, Bergmann P, Gillet C, et al:Long-term irreversibility of bone loss after surgery for primary hyperparathyroidism. Arch Intern Med 150:1495-1497, 1990
  pubmed

• 13) Rao DS, Wilson RJ, Kleerekoper M, et al:Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism:evidence for biphasic disease course. J Clin Endocrinol Metab 67:1294-1298, 1988
  pubmed

• 14) Lifschitz BM, Barzel US:Parathyroid surgery in the aged. J Gerontol 36:573-575, 1981
  pubmed

• 15) Fiatarone MA, Steel K, Egdahl RH:Hyperparathyroidism inthe elderly. J Am Geriatr Soc 29:343-348, 1981

• 16) 竹内秀雄, 松田公志, 荒井陽一, ほか:原発性上皮小体機能亢進症の臨床的検討-手術適応と手術手技についての考察-. 泌尿紀要 37:1191-1195, 1991

• 17) Galbraith RA, Michnovicz JJ:The effects of cimetidine on the oxidative metabolism of estradiol. N Eng J Med 321:269-274, 1989

• 18) Shane E:Medical management of a symptomatic primary hyperparathyroidism. J Bone Miner Res 6 (suppl2):S131-S134, 1991

• 19) McDermott MT, Perloff JJ, Kidd GS:Effects of mild a symptomatic primary hyperparathyroidism on bone mass in women with and without estrogen replacement therapy. J Bone Miner Res 9:509-514, 1994

• 20) Consensus Development Conference Panel:Diagnosis and management of asymptomatic primary hyperparathyroidism, consensus development conference statement. Ann Intern Med 114:593-597, 1991
  pubmed

• 21) Morrison NA, Qi JC, Tokita A, et al:Prediction of bone density from vitamin D receptor alleles. Nature 367:284-287, 1994
  pubmed

P.151 掲載の参考文献

• 1) Abe E, Miyaura C, Sakagami H, et al:Differentiation of mouse myeloid leukemia cells induced by 1.25-dihydroxyvitamin D. Proc Natl Acad Sci USA 78:4990-4994, 1981

• 2) Manolagas SC, Hustmyer FG, Yu XP:Immunomodulating properties of 1.25-dihydroxyvitamin D3. Kidney Int 38:S9-S16, 1990

• 3) Spencer R, Charman M, Entage JS, et al:Production and properties of vitamin-D-induced mRNA for chick calcium-binding protein. Eur J Biochem 71:399-409, 1976

• 4) Manolagas SC, Burton DW, Deflos LJ:1,25-dihydroxyvitamin D3 stimulates the alkaline phosphatase activity of osteoblast-likecells. J Biol Chem 256:7115-7117, 1981

• 5) Price PA, Baukol SA:1,25-dihydroxyvitamin D3 increases serum levels of the vitamin k-dependent bone protein. Biochem Biophys Res Commun 99:928-935, 1981
  pubmed

• 6) Rasmussen h, Fontaine O, Max EE, et al:The effect of 1α-hydroxyvitamin D3 administration on calcium transport in chick intestine brush border membrane vesicles. J Biol Chem 254:2993-2999, 1979

• 7) Kurokawa K:Calcium-regulating hormones and the kidney. Kidney Int 32:760-771, 1987
  pubmed

• 8) 高野朋子, 黒川清:カルシウム調節系におけるビタミンDと腎臓. 臨床透析 6:7-13, 1990

• 9) Cantley LK, Russell J, Lettieri D, et al:1. 25-dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovin eparathyroid cells in tissue culture. Endocrinology 117:2114-2119, 1985
  pubmed

• 10) Russell J, Lettieri D, Sherwood LM:Suppression by 1.25 (OH) 2D3 of transcription of the pre-proparathyroid hormone gene. Endocrinology 119:2864-2866, 1986
  pubmed

• 11) Reichel H, Koeffler HP, Norman AW:The role of the vitamin D endocrine system in health and disease. N Eng J Med 320:980-991, 1989

• 12) Tsouks CD, Prowedin DM, Manolagas SC:1. 25-Dihydroxyvitamin D3:A novel immunoregulatory hormone. Science 224:1438-1440, 1984

• 13) Zarrabeitia MT, Riancho JA, Rodriguez-Valverde V, et al:Role of monocytes in the inhibitory effect of calcitriol on PHA-stimulated lymphocytes. Blut 54:343-349, 1987
  pubmed

• 14) Lemire JM, Adams JS, Sakai R, et al:1α,-25-dihydroxyvitamin D3 inhibits γ-interferon synthesis by normal huhman peripheral blood lymphocytes. Proc Natl Acad Sci USA 84:3385-3389, 1987

• 15) Reichel H, Koeffler HP, Tobler A, et al:1α, 25-dihydroxyvitamin D3 inhibits γ-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci USA 84:3385-3389, 1987

• 16) Provvedini DM, Tsoukas CD, Deftos LJ, et al:1α, 25-dihydroxyvitamin D3-binding macromolecules in human B lymphocytes:Effects on immunoglobulin production. J Immunol 136:2734-2740, 1986

• 17) Connor RI, Rigby WFC:1,25-Dihydroxyvitamin Dinhibits productive infection of human monocytes by HIV-1. Biochem Biophys Res Comm 176:852-859, 1991

• 18) Tabata T, Suzuki R, Kikunami K, et al:The effect of 1α-hydroxyvitamin D3 on cell-mediated immunity in hemodialysis patients. J Clin Endocrinol Metab 63:1218-1221, 1986

• 19) 宮坂信元:リウマチ病の原因. からだの科学 (増刊) (柏崎禎夫, 編), pp.10-14, 東京, 日本評論社, 1993

• 20) Bhalla AK, Amento EP, Sergo B, et al:1,25-dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol 133:1748-1754, 1984

• 21) Larsen CG, Kristensen M, Paludan K, et al:1.25-Dihydroxyvitamin D is a potentregulator of interleukin-1 induced in terleukin-8 expression and production. Biochem Biophys Res Comm 176:1020-1026, 1991

• 22) Kreutz M, Andreesen R:Induction of human monocyte to macrophage maturation in vitro by 1, 25-dihydroxyvitamin D3. Blood 76:2457-2461, 1990
  pubmed

• 23) Rico H, Hernandez ER, Comez-Castresana F, et al:Osteopenia in rheumatoid arthritis:a biochemical, hormonal and histomorphometric study. Clin Rheum 9:63-68, 1990

• 24) Mawer EB, Hayes ME, Still PE, et al:Evidence for nonrenal synthesis of l, 25-dihydroxyvitamin D in patients with in flammatory arthritis. J Bone Miner Res 6:733-739, 1991

• 25) 山高弘義, 堀内三郎:関節炎における血中および関節液中カルシウム代謝調節因子の動態について-慢性関節リウマチと変形性関節症との比較を中心に-. 岩手医誌 44:539-552, 1992

• 26) Sambrook PN, Ansell BM, Foster S, et al:Bone turnover in early rheumatoid arthritis. 2. Longitudinal bone density studies. Ann Rheum Dis 44:580-584, 1985
  pubmed

• 27) 上好昭孝, 大田喜一郎, 岡本幸春, ほか:慢性関節リウマチの骨病変とカルシウム調節ホルモン. リウマチ 29:340-357, 1990

• 28) 星野 潤, 上好昭孝, 木浦賀文, ほか:RAの治療における免疫調節剤と活性型アV.D3の効用. 中部整災誌 32:795-797, 1989

検査法

P.163 掲載の参考文献

• 1) Kerolus G, Clayburne G, Schumacher HR:Is it mandaory to examine synovial fluid Promptly after arthritis. Arthritis Rheum 32:271, 1989

• 2) 米田操, 前田依子:関節液中の結晶の見方. 検査と技術 20:805-810, 1992

• 3) Schumacher HR, Reginato AJ:Apatite crystals and other calcium phosphates. In:Atlas of Synovial Fluid Analysis and Crystal Identification. p.135, London, Lea Febiger, 1991

• 4) Paul H, Reginato AJ, Schumacher HR:Alizalin red S Stainig as a screening test to detect calcium compounds in synovial fluid. Arthritis Rheum 26:191-200, 1983

• 5) Swan AJ, Dieppe PA:Hunting for apatite crystal in synovial fluid, is it worth it and how to do it. In:Rheumatology, (Ed, Klippe HJ, Dieppe AP), 7, 16, 6-16, 8, London, Mosby, 1994

• 6) Wild JH, ZVaifler NJ:An office techniqne for identiflying crystal in synovial fluid. Am Fam Physician 12:72-81, 1975

• 7) 井上康二:リピド微細結晶性関節炎. リウマチ病セミナ-III (七川歡次, 監修), pp.17-25, 大阪, 永井書店, 1992

• 8) Schumacher HR:Crystal arthritis. other crystals. In:rheumatology. (Ed, Klippel HJ, Dieppe AP), 7, 15. 1-15. 4, London, Mosby, 1994

• 9) Hoffman GS, Schumacher HR, Paul H, et al:Calcium oxalate microcrystalline associated arthritis in end stage renal disease. Ann Intern Med 97:36-42, 1982
  pubmed

• 10) Schumacher HR, Reginato AJ, Pullman S, et al:Synovial oxalate deposition conplicating rheumatoid arthritis with amyloidosis and renal failure. J Reumatol 14:361-6, 1987

• 11) Schumacher HR, Reginato AJ:Charcot-Leyden cystals. In:Atlas of Synovial Fluid Analysis and Crystal Identification. p.90, London, Lea Febiger, 1991

• 12) Weller PF, Bach D, Austen KF:Human eosinophil lysophospholipase:the sole protein component of Charcot-Leyden crystals. J Immunol 128:1346, 1982
  pubmed

• 13) Schumacher HR, Reginato AJ:Immnoglobulin crystals. In:Atlas of Synovial Fluid Analysis and Crystal Identification. p.193, London, Lea Febiger, 1991

• 14) Jennette JC, Wilkman AS, Bonson JD:IgD myeloma with intra-cytoplasmic crysatalline inclusion. Am J Clin Pathol 75:213, 1981

• 15) Schumacher HR, Reginato AJ:Hemoglobin and hematoidin crystals. In:Atlas of Synovial Fluid Analysis and Crystal Identification. p.201, London, Lea Febiger, 1991

• 16) Gordon C, Swan PA, Dieppe PA:Detection of crystals in synovial fluids by light microscopy:sensitivity and reliability. Ann Rheum Dis 48:737-42, 1981

P.174 掲載の参考文献

• 1) Hauschka PV, Lian JB, Cole DEC, et al:Osteocalcin and matrix gla protein:Vitamin K-dependent proteins in bone. Physiol Rev 69:990-1047, 1989

• 2) Gernero P, Grimaux M, Segun P, et al:Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Min Res 9:255-265, 1994

• 3) Deacon AC, Hulme P, Heps R, et al:Estimation of whole body bone resorption rate:A comparison of urinary total hydroxyproline excretion with two radioisotopic tracer methods in osteoporosis. Clin Ckim Acta 166:297-306, 1987

• 4) Eyre DR, Paz MA, Gallop PM:Cross-linking in collagen and elastin. Ann Rev Biochem 53:717-748, 1984
  pubmed

• 5) Seyedin SM, Kung VT, Daniloff YN, et al:Immunoassay for urinary pyridinoline:The new marker of bone resorption. J Bone Min Res 8:635-641, 1993

• 6) Risteli J, Elomaa I, Niemi S, et al:Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I coilagen:A new serum marker of bone collagen degradation. Clin Chem 39:635-640, 1993
  pubmed

• 7) Alexandersen P, Schlemmer A, Riis BJ, et al:"Circadian variation in "CrossLaps":A new marker of bone resorption. J Bone Min Res 9 (supple 1):s190, 1994

• 8) Hanson DA, Weis MAE, Bollen AM, et al:A specific immunoassay for monitoring human bone resorption:Quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Min Res 7:1251-1258, 1992

• 9) Yoshitaka H, Uchida A, Kudawara I, et al:Serum tartrate-resistant acid phosphatase as a tumor marker in giant cell of bone. Calcif Tissue Int 50s:43, 1992

• 10) Piedra C, Torres R, Rapado A, et al:Serum tartrate-resistant acid phosphatase and bone mineral content in posmenopausal osteoporosis. Calcif Tissue Int 45:58-60, 1989

• 11) Brown JP, et al:Serum bone Gla-protein:A specific marker for bone formation in postmenopausal osteoporosis. Lancet 1:1091-1093, 1984
  pubmed

• 12) Hosoda K, Eguchi H, Nakamoto T, et al:Sandwich immunoassay for intact human osteocalcin. Clin Chem 38:2233-2238, 1992
  pubmed

• 13) Ebeling PR, Peterson JM, Riggs BL:Utility of Type I Procollagen Propeptide Assays for Assessing Abnormalities in Metabolic Bone Diseases. J Bone Mineral Res 7:1243-1250, 1992

• 14) Eriksen EF, Charles P, Melsen F, et al:Serum Markers of Type I Collagen Formation and Degradation in Metabolic Bone Disease:Correlation with Bone Histomorphometry. J Bone Mineral Res 8:127-132, 1993
  pubmed

• 15) Masuhara K, Suzuki S, Yoshikawa H, et al:Development of a monoclonal antibody specific for human bone alkaline phosphatase. Bone and Mineral 17:182-186, 1992
  pubmed

• 16) Garnero P, Delmas PD:Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endo Met 77:1046-1053, 1993

• 17) Harris WH, Heaney RP:Skeletal renewal and metabolic bone disease. N Eng J Med 280:253-2259, 1969

• 18) Delmas PD, et al:Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Min Res 6:639-644, 1991

• 19) Akesson K, Vergnaud P, Gineyts E, et al:Impairment of bone turnover in elderly women with hip fracture. Calcif Tissue Int 53:162-169, 1993
  pubmed

• 20) Hodges SJ, Philkington MJ, Stamp TCB, et al:Decreassed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck. Bone 12:387-389, 1991

• 21) Szulc P, Chapuy MC, Meunier PJ, et al:Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 91:1769-1774, 1993
  pubmed

P.183 掲載の参考文献

• 1) Innis MA, Gelfand DH, Sninsky JJ, et al:PCR 実験マニュアル (斉藤 隆, 監訳), HBJ 出版局, 1991

• 2) Chelly J, Kaplan J-C, Maire P, et al:Transcription of the dystrophin gene in human muscle and non-muscle tissues. Nature 333:858-860, 1988
  pubmed

• 3) 上坂 等:Competitive PCR. 臨床免疫 26 (11):1282-1288, 1994

• 4) 西村泰治:HLA class II分子に結合するペプチド. 医学のあゆみ 168:1113-9, 1994
  Medical*Online

• 5) Struyk L, Hawes GE, Chatila MK, et al:T cell receptors in rheumatoid arthritis. Arthritis Rheum 38:577-589, 1995
  pubmed

• 6) Black SH:Preimplantation genetic diagnosis. Curr Opin Pediatr 6:712-6, 1994
  pubmed

• 7) Tohyama J, Nanba E, Ohno K:Hypoxanthine-guanine phosphoribosyl transferase (HPRT) deficiency:identification of point mutations in japanese patients with Lesch-Nyhan syndrome and hereditary gout and their permanent expression in an HPRT-deficient mouse cell line. Hum Genet 93:175-81, 1994

• 8) 梶井 正, 松田一郎, 山村研一:医科遺伝学. 南江堂, 1994

P.193 掲載の参考文献

• 1) Mizuochi T, Taniguchi T, Shimizu A, et al:Structural and numerical variations of the carbohydrate moiety of immunoglobulin G. J Immunol 129:2016-2020, 1982
  pubmed

• 2) Parekh RB, Dwek RA, Sutton BJ, et al:Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316:452-457, 1985
  pubmed

• 3) Nose M, Wigzell H:Biological significance of carbohydrate chains on monoclonal antibody. Proc Natl Acad Sci USA 80:6632-6336, 1983
  pubmed

• 4) Heyman B, Nose M, Weigle W:Carbohydrate chains on IgG 2b:a requirement for efficient feedback immunosuppression. J Immunol 134:4018-4023:1985

• 5) Mizuochi T:Microscale sequencing of N-linked oligosaccharides of glycoproteins using hydrazinolysis, Bio-Gel P-4, and sequencing exoglycosidase digestion. In Methods in Molecular Biology (Ed, Hounsell E), Vol. 14, pp. 55-68, New Jersey, Humana Press, 1993

• 6) 水落次男:リウマトイド因子のリアクタント-慢性関節リウマチ患者由来IgGにみられる糖鎖の構造異常. 臨床免疫 17:977-984, 1985

• 7) 中田宗宏, 水落次男:免疫グロブリンの糖鎖構造. 臨床検査 39:636-642, 1995

• 8) Mizuochi T, Hamako J, Nose M, et al:Structural changes in the oligosaccharide chains of IgG in autoimmune MRL/Mp-lpr/lpr mice. J Immunol 145:1794-1798, 1990
  pubmed

• 9) 水落次男:早期リウマチにおけるリウマチ因子の測定. リウマチ科 12:337-343, 1994

• 10) 中田宗宏, 水落次男:リウマトイド因子と糖鎖構造. 診断と治療 83:1173-1177, 1995

生物学的反応

P.205 掲載の参考文献

• 1) Muhlen CA, Tan EM:Autoantibodies in the diagnosis of systemic rheumatic disease. semin Arthritis Rheum 24:323-358, 1995

• 2) 三森経世:自己抗体対応抗原としての非ヒストソ淡白. 日本臨牀 46:790-796, 1988

• 3) Bootsma H, Spronk P, Derksen R, et al:Prevention of relapses in systemic lupus erythe matosus. The Lancet 345:1595-1599, 1995

• 4) 大曽根康夫:自己抗原遺伝子の解析, 自己免疫疾患 (山本一彦, 編), pp.60-69, 東京, 羊土社, 1994

• 5) 志水正敏, 佐伯修, 林満寿彦, ほか:混合性結合組織病における抗RNP抗体産生の機序と抗体の病因論的意義. 厚生省特異疾患混合性結合組織病調査研究班平成6年度研究報告書, pp.67-68, 1995

P.213 掲載の参考文献

• 1) Cush JJ, Lipsky PE:Cellular basis for rheumatoid inflammation. Clin Orthop 265:9-22, 1991
  pubmed

• 2) Harris FD Jr:Rheumatoid arthritis:pathoplysiology and implications for therapy. N Engl J Med 322:1277-1289, 1990

• 3) 塩沢俊一:血管内皮細胞と関節炎. In リウマチ病セミナーIII (七川歡次, 監修), pp.176-186, 大阪, 永井書店, 1992

• 4) Shimizu Y, Newman W, Tanaka Y, et al:Lymphocyte interactions with endothelial cells. Immunol Today, 13:106-112, 1992
  pubmed

• 5) Springer TA:Adhesion receptors for the immune system. Nature 346:425-434, 1990
  pubmed

• 6) Dustin ML, Springer TA:Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu Rev Immunol 9:27-66, 1991
  pubmed

• 7) Springer TA:Traffic signals for lymphocyte recirculation and leukocyte emigration:The multistep paradigm. Cell 76:301-314, 1994
  pubmed

• 8) Shimizu Y, Van Sevnter GA, Horgan KJ, et al:Roles of adhesion molecules in T-cell recognition:Fundamental similarities between four imtegrius on resting human T cells (LFA-1, VLA-4, LA-5, VLA-6) in expression, Binding, and costimulation. Immunol Rev 114:109-143, 1990

• 9) Nojima Y, Humphrie MJ, Mould AP, et al:VLA-4 mediated CD 3-dependent CD 4 + Tcellactivation via the CS1 alternatively spliced domain of. fibronectin. J Exp Med 172:1185-1192, 1990

• 10) van Seventer GA, Boncini E, Yamada H, et al:Costimulation of T cell receptor/CD 3-mediated activation of resting human CD 4 + T cells by leukocyte funtion-associated antigen-1 ligand inter celluar cell adhesionmolecule-1 involves prolonged inositol phospholipid hydrolysis and sustained increase of intracellular Ca2+levels. J Immunol 149:3872-3880, 1992

• 11) Butcher EC:Leukocyte-endotherial cell rcognition:three (or more) steps to specificity and diversity. Cell. 67:1033-1036, 1991
  pubmed

• 12) Zimmerman GA, Prescott SM, Melntyre TM:Endtherial cell interactions with granulocytes:tethering and signaling molecules. Immunal Today 13:93-100, 1992

• 13) Lawrence MB, Springer JA:Leukocytes roll on a selectin at phrysiologic flow rates:distinction from and prerequisite for adhesion throngh integrins. Cell 65:859-873, 1991

• 14) Cavender D, Haskard D, Yu C-L, et al:Pathways to chronic inflammation in rheumatoid synovitis. Federation Proc 46:113-117, 1987

• 15) Veale D, Yanni G, Rogers S:Reduced synovial membraw macrophage numbers, ELAM-1 expression, and liming layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum 36:893-900, 1993

• 16) Dustin ML, Springer TA:T-cell receptor cross-linkiny transienthy stimulates adhesiveness through LFA-1. Nature 341:619-624, 1989
  pubmed

• 17) Tanaka Y, Adams DH, Hubscher S, et al:T-cell adhesion induced by protes glycan-immobilized cytokine MIP-1β. Nature 361:79-82, 1993

• 18) Gerritsen ME, Kelley KA, Ligon G, et al:Regulation of the expression of intercellular adhesion molecule 1 in cultured human endothelial cells derived from rheumatoid synovium. Arthritis Rheum 36:593-602, 1993
  pubmed

• 19) Burmester GR, Yu DTY, Irani AM, et al:Ia+Tcell in synovial fluid and tissues of patients with rheumatoidarthritis. Arthritis Rheum 24:1370-1376, 1981

• 20) Pitzalis C, Kingsley G, Murplry J, et al:Abnormal distribution of helper-inducer and suppressor-inducer T lymphocyte subsets in the rheumatoid joint. Clin Immunol Immunopathol 45:252-258, 1987

• 21) Hemler ME, glass D, Coblyn JS, et al:Very late activation antigens on rheumatoid synovial fluid T lymphocytes:Association with stages of T cell activation. J Clin Invest 78:696-702, 1986
  pubmed

• 22) Laffon A, Sanchez-Madrid F, de Landazuri MO, et al:Very late activation antigen on synovial fluid T cell from patients with rheumatoid arthritis and other rheumatic diseases. Arthritis Rheum 32:386-392, 1989

• 23) Modales-Ducret J, Wayner E, Elices MJ:α4/βintegrin (VLA-4) ligands in arthritis:vascular cell adhesion molecule-1 expression in synovium and on fibroblant-like synoviocytes. J Immunol 149:1424-, 1992

• 24) Sewell KL, Trentham DE:Pathogenesis of rheumatoid arthritis. Lancet 341:283-286, 1993
  pubmed

• 25) Miyake S, Yagita H, Maruyama T, et al:β1 integrin-mediated interaction with extracellular matrix proteins regulaten cytokine gene expression in synovial fluid cells of rheumatoid arthritis patients. J Exp Med 177:863-868, 1993

• 26) Yokota A, Murata N, Saiki O, et al:High avidity state of LFA-1 (Leukocyte function associated antigen-1) on rheumatoid synovial fluid T lymphocytes. J Immunol, In press

P.220 掲載の参考文献

• 1) Bjorkman PJ, Parham J:Structure, function, and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem 59:253-258, 1990

• 2) Kappes D, Strominger JL:Human class II major histocompatibility complex genes and proteins. Annu Rev Biochem 57:991-1028, 1988
  pubmed

• 3) Stastny P:Association of the B-cell alloantigen DRW 4 with rheumatoid arthritis. N Engl J Med 298:869-871, 1978

• 4) Ollier W, Thomson W:Population genetics of rhumatoid arthritis. Rhem dis Clin North Am 18:741-759, 1992

• 5) Ohta N, Nishimura YK, Tanimoto K, et al:Association between HLA and Japanese patients with rheumatoid arthritis. Hum Immunol 5:123-132, 1982
  pubmed

• 6) Brown J, Gorga J, Stern L, et al:Threedimentional structure of the human class II histocompatibility antigen HLA-DR 1. Nature 364:33-39, 1993

• 7) Bjorkman PJ, Saper MA, Samraoui B, et al:The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigen. Nature 39:512-518, 1987

• 8) Stren LJ, Brown JH, Jardetzky TS, et al:Crystal structure of the human class II MHC protein HLA-DR 1 complexed with an influenza virus peptide. Nature 368:215-221, 1994

• 9) Schwarz RH:T-lymphocyte recognition of antigen in association with gene products of the MHC-complex. Annu Rev Immunol 3:237-261, 1985

• 10) Harris ED:Reumatoid arthritis:pathophysiology and implications for therapy. N Eng J Med 322:1277-1289, 1990

• 11) Hammer L, Gallazzi F, Bone E, et al:Peptide binding specificity of HLA-DR 4 molecules:correlation with rheumatoid arthritis association. J Exp Med 181:1847-1855, 1995

• 12) Bell JI, Denney D, Foster L, et al:Allelic variationb in the DR subregion of the human major histocompatibility complex. Proc Natl Acad Sci USA 84:6234-6238, 1987
  pubmed

• 13) 土屋邦喜, 西村泰治, 笹月健彦:RAの遺伝的素因. 日本臨牀 50:438-443, 1992

• 14) Gregersen PK, Silever J, Winchester RJ:The shared epitope hypothesis:an approach to understanding the molecular genetics of susceptibility to rheumatoid arthrisis. Arthritis Rheum 30:1205-1213, 1987

• 15) Wordsworth BP, Stedeford J, Rosenber WMC, et al:Limited heterogeneity of the HLA class II contribution to susceptibility to rheumatoid arthritis is suggested by positive association with HLA-DR 4, DR 1 and DRw10. Br J Rheumatol 30:178-180, 1991

• 16) Van Seben D, Hazes JMW, Zwenderman AH, et al:Association of HLA-DR 4 with a more progressive disease course in patients with rheumatoid arthritis:results of a follow up study. Arthritis Rheum 34:822-830, 1921

• 17) Weyand C, Hicok K, Conn D, Goronzy J:The influence of HLA-DRB 1 genes on disease severity in rheumatoid arthriris. Ann Intern Med 117:801-806, 1992

• 18) 水木信久, 大野重昭:HLA抗原とT細胞系の免疫応答. 臨床免疫 25:1021-1044, 1993

• 19) Sinha AA, Lopez MT, McDevitt HO:Autoimm une diseases:the failure of self tolerance. Science 248:1380-1388, 1990

治療と副作用

P.235 掲載の参考文献

• 1) Ochi T, Hakomori S, Adachi M, et al:The presence of a myeloid cell population showing strong reactivity with monoclonal antibody dirrected to difucosylty pe2 chain in epiphyseal bone marrow adjacent to joints affected with rheumatoid arthritis and its presence in the corresponding normal and non-RA bone marrow. J Rheumatol 15:1609-1615, 1988

• 2) 越智隆弘:重症慢性関節リウマチの病態. リウマチ 30:287-300, 1990

• 3) Tomita T, Kashiwagi N, Shimaoka Y, et al:Phenotypic characteristics of bone marrow cells in patients with rheumatoid arthritis. J Rheumatol 21:1608-1614, 1994
  pubmed

• 4) 富田哲也, 島岡康則, 柏木伸仁, ら:RA骨髄に認められる細胞組成の変化. 炎症と免疫 2:629-636, 1994

• 5) Kaisho T, Oritani K, Ishikawa J, et al:Human bone marrow stromal cell lines from myeloma and rheumatoid arthritis that can support murine pre-B cell growth. J Immunol 149:4088-4095, 1992
  pubmed

• 6) Kaisho T, Ishikawa J, Oritani K, et al:BST-1, a novel surface molecule of bone marrow stromal cell lines that facilitates pre-B cell growth. Proc Natl Acad Sci USA 91:5325-5329, 1994

• 7) 石川淳, 石原克彦, 平野俊夫:RA骨髄由来の間質細胞によるプレB細胞増殖支持機構. 炎症と免疫 2:637-642, 1994
  Medical*Online

• 8) 豊崎朋子, 鈴木隆二:RA骨髄と滑膜より誘導されるナース細胞と組織浸潤リンパ球との相互作用. 炎症と免疫 2:643-649, 1994
  Medical*Online

• 9) Hirohata S, Yanagida T, Koiwa M, et al:Selective induction of IgM rheumatoid factor by CD14+monocyte-lineage cells generated from bone marrow of patients with rheumatoid arthritis. Arthritis Rheum 38:384-388, 1995
  pubmed

• 10) 広畑俊成:RA骨髄由来のCD14+細胞によるリウマトイド因子産生の特異的な増強. 炎症と免疫 2:650-656, 1994

• 11) Hakomori S, Nudelman E, Levery SB, et al:Nobel fucolipids accumulating in human adenocarcinoma. I. Glycolipids with di-or trifucosylated type 2 chain. J Biol Chem 259:4672-80, 1984

• 12) Wakitani S, Owaki H, Ochi T, et al:Elevated interleukin-1 level in polymorphonuclear cells accumulating in bone marrow adjacent to the affected joint with severe rheumatoid arthritis. Jpn J Rheumatol 21:830-835, 1994

• 13) Ochi T, Hakomori S, Fujimoto M, et al:Therapeutic effect of intradermal injections with difucosyl lactosamine (dimeric Lex) on patients with rheumatoid arthritis. J Rheumatol 20:2038-45, 1993
  pubmed

• 14) Shimoda N, Muramatsu H, Osawa T, et al:Carbohydrate moieties of peanut agglutinin receptors isolated from human gastriccancer cells. J Biochem 102:657-664, 1987

• 15) Arnett FC, Edworthy SM, Bloch DA, et al:The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
  pubmed

• 16) The Cooperating Clinics Committee of the American Rheumatism Association:A seven day variability study of 499 patients with peripheral rheumatoid arthritis. Arthritis Rheum 8:302-334, 1965

• 17) Steinbrocker O, Traeger CH, Batterman RC:Therapeutic criteria in rheumatoid arthritis. JAMA 140:659-662, 1949

• 18) Ochi T, Iwase R, Yonemasu K, et al:Natural course of joint destruction and fluctuation of serum Clq levels in patients with rheumatoid arthritis. Arthritis Rheum 31:37-43, 1988

• 19) Fukushi Y, Hakomori S, Nudelman E, et al:Novel fucolipids accumulating in human adenocarcinoma. II. selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain. J Biol Chem 259:4681-4685, 1984

• 20) 越智隆弘, 小野啓郎:慢性関節リウマチの経口投与金療法における血中金濃度と臨床効果について. 臨床リウマチ 1:300-307, 1988

• 21) Gammon R, Clayton E, Wheeler E, et al:Urticalial vasculitis. Report of a case and review of the literature. Arch Dermatol 115:76-80, 1979

• 22) 柏木伸仁, 越智隆弘:ヒト胃癌細胞, Kato III 由来糖鎖複合体 (TCA) が自己リソパ球混合培養反応に与える影響. リウマチ 32:206-214, 1992

• 23) Phillips ML, Nudelman E, Gaeta A, et al:ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science 250:1130-1135, 1990

• 24) Furukawa K, Kobata A:IgG galactosylation-Its biological significance and pathology.
  pubmed

P.242 掲載の参考文献

• 1) Stern JJ:Acute glaucoma during cortisone therapy. Am J Ophthalmol 36:389-390, 1953
  pubmed

• 2) Covell LL:Glaucome induced by systemic steroid therapy. Am J Ophthalmol 45:108-109, 1954

• 3) Francois J:Cortisone et tension oculaire. Ann Ocul 187:805-816, 1954
  pubmed

• 4) Goldmann H:Cortisone glaucoma. Arch Ophthalmol 68:621-626, 1954

• 5) Caldwell JR, Furst DE:The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis. Semin Arthritis Rheum 21:1-11, 1991
  pubmed

• 6) Armaly MF:Effects of corticosteroids on intraocular pressure and fluid dynamics. I. The effect of dexamethazone in the normal eye. Arch Opthalmol 70:482-491, 1963

• 7) Francois J:The importance of the mucopolysaccharides in intraocular pressure regulation. Invest Opthalmol Vis Sci 14:173-176, 1975

• 8) Synder RW, Stamer WD, Kramer TR, Seftor RE:Corticosteroid treatment and trabecular meshwork proteases in cell and organ culture supernatants. Exp Eye Res 57:401-468, 1989

• 9) Bill A:The dranage of aqueous humor. Invest Opthalmol Vis Sci 14:1-3, 1975

• 10) Weinreb RN, Mitchell MD, Polansky JR:Prostagrandin production by human trabecular cells. In vitro inhibition by dexamethasone. Invest Ophthalmol Vis Sci 24:1541-1545, 1989

• 11) Berkowitz JS, David SD, Shoji JS, et al:Ocular complications in renal transplant recipients.Am J Med 55:492-495, 1973

• 12) Ohji M, Kinoshita S, Kumayama Y:Marked intraocular pressure response to instillation of corticosteroids in children. Am J Ophthalmol 112:450-454, 1991

• 13) 大口正樹, 大野重昭, 竹内勉, ほか:小児における副腎皮質ホルモン剤内服の眼圧に及ぼす影響. 臨眼 31:781-785, 1977

• 14) 東 郁郎:ステロイド緑内障の症候. 眼科 32:125-129, 1990

• 15) 竹内麗子, 桑山泰明, 志賀早苗, ほか:ステロイド緑内障に対するトラベクロトミー. あたらしい眼科 9:1181-1183, 1992

P.250 掲載の参考文献

• 1) 森本靖彦, 花崎信夫, 宮武明彦, ほか:慢性疾患ステロイド治療時の副腎皮質機能抑制に及ぼすステロイド製剤の種類, 投与量, 投与方法の影響について. 日内会誌 67:57-68, 1978

• 2) Buchanan WW, Stephen LJ, Buchanan HM:are 'homeopathic' doses of oral corticosteroids effective in rheumatoid arthritis? Clin Exp Rheumatol 6:281-284, 1988
  pubmed

• 3) Weiss MM:Corticosteroids in rheumatoid arthritis. Semin Arthritis & Rheum 19:9-21, 1989

• 4) 大山建司:グルココルチコイドの作用機序. 小児内科 25:183-186, 1993

• 5) 元村卓嗣, 佐藤文三:ステロイド受容体と作用発現まで. 治療学 27:525-529, 1993
  Medical*Online

• 6) Steinberg AD:免疫抑制製剤使用の原則. 'リウマチ入門第9版 ' (アメリカ関節炎財団, 編), 日本リウマチ学会訳, pp.501-510, 日本リウマチ学会, 1990

• 7) 森本靖彦:グルココルチコイドの副作用とその対策. 最新医学 39:1578-1589, 1984
  Medical*Online

• 8) 川合真一:ステロイド剤. リウマチ学 (塩川優一, 監修), pp.1255-1267, 東京, 同文書院, 1989

• 9) Felson DT, Anderson JJ:across-study evaluation of association between steroid dose and bolus steroids and avascular necrois of bone. Lancet april 18:902-905, 1987

• 10) 小松原良雄:osteoporosisの評価法. リウマチ病セミナーI (七川歡次, 監修), pp.261-271, 大阪, 永井書店, 1990

• 11) 小泉雅彦, 森茂樹, 上田孝文, ほか:RA における骨粗鬆症の推移-SPA法, DIP法による骨塩定量-. 骨関節靭帯 6:863-869, 1993

• 12) Olbright T, Benker G:glucocorticoid-induced osteoporosis:pathogenesis, prevention and treatment, with special regard to the rheumatic diseases. J intern Med 234:237-244, 1993

• 13) Silverman SL:ステロイド骨粗鬆症の予防と治療-ACR学会レポート-. Rheumatology today 8:10-11, Excerpta Medica, 1995

手術

P.265 掲載の参考文献

• 1) 大田 寛:慢性関節リウマチの顎関節. リウマチ病セミナーII (七川歡次, 監修), pp. 110-116, 大阪, 永井書店, 1991

• 2) Chalmers IM, Blair GS:Rheumatoid arthritis of the temporomandibular joint. Quart J Med 17:369-386, 1973

• 3) 横山良樹, 川井 章, 井上 一, ほか:慢性関節リウマチ患者の顎関節障害について. 整形外科 39:346-350, 1988

• 4) Stern NS, Trop RC, Balk P:Total temporomandibular joint replacement in a patient with rheumatoid arthritis:report of a Case. JADA 112:491-495, 1986

• 5) Kent JN, Carlton DM, Zide MF, et al:Rheumatoid disease and related arthropaties. Oral Surg 61:423-439, 1986

• 6) 菅原利夫, 川本知明, 森 悦秀, ほか:慢性関節リウマチの顎関節破壊による呼吸困難症例に対する顎関節全置換術の応用. 日科誌 42:602-612, 1993

• 7) Sugahara T, Mori Y, Kawamoto T, et al:Obstructive sleep apnea associated with temporomandibular joint destruction by rheumatoid arthritis:report of a case. J Maxillofac Surg 52:876-879, 1994

• 8) Wolford LM, Cottrell DA, Henry CH:Temporomandibular joint reconstruction of the complex patient with the techmedica custom-made total joint prosthesis. J Oral Maxillofac Surg 52:2-10, 1994
  pubmed

• 9) Oshrain HI, Sackler A:Involvement of the temporomandibular joint in a case of rheumatoid arthritis. Oral Surg 8:1039-1043, 1995

• 10) Robinson M:Temporomandibular ankylosis corrected by creating a false stainless steel fossa. J South Calif Dent Assoc 6:186-189, 1960

• 11) Christensen RW:Mandibular joint arthritis corrected by the insertion of a cast vitallium glenoid fossa prosthesis:a new technique. Oral Surg 17:712-722, 1964

• 12) Morgan DH:Surgical correction of temporomandibular joint arthritis. J Oral Surg 33:766-773, 1975
  pubmed

• 13) Kent JN, Homsy CA, Gross BD, et al:Pilot studies of a porous implant in dentistry and oral surgery. J Oral Surg 30:608-615, 1972
  pubmed

• 14) Kent JN, Levelle WE, Dolan KD:Condylar reconstruction:treatment-planning. Oral Surg 37:489-497, 1974

• 15) Kent JN, Homsy CA, Hinds EC:Proplast in dental facial reconstruction. Oral Surg 35:909-911, 1975

• 16) Kiehn CL, DesPretz JP, Converse CF:A new procedure for total temporomandibular joint replacement-Case Report. Plast Reconstr Surg 53:221-226, 19. 74

• 17) Kummoona R:Functional rehabilitation of ankylosed temporomandibular joints. Oral Surg 46:495-505, 1978
  pubmed

• 18) Kent JN, Misik DJ, Akin R, et al:Temporomandibular joint condylar prosthesis:a ten-year report. J Oral Maxillofac Surg 41:245-254, 1983

• 19) Kent JN, Block MS, Homsy CA, et al:Experience with a polymer glenoid fossa prosthesis for partial or total temporomandibular joint reconstruction. J Oral Maxillofac Surg 44:520-533, 1986
  pubmed

• 20) Kent JN, Block MS, Halpern J, et al:Update on the vitek partial and total temporomandibular joint Systems. J Oral Maxillofac Surg 51:408-415, 1993
  pubmed

• 21) Robinson M:Tempolomandibular ankylosis corrected by creating a false silastic sponge fossa. J South Calif Dent Assoc 36:14-17, 1968

• 22) Dawson DJ, Kane DW, McEvoy D:Obstructive sleep apnea associated with adult-acquired micrognathia from rhenmatoid arthritis. Am Rev Resp Dis 127:245-247, 1983

• 23) Guilleminaut C, Tilkian A, Dement WC:The sleep apnea syndromes. Ann Rev Med 27:465-484, 1976

• 24) Redlund-Jonell I:Radiographic measurement of severe temporomandibular joint destruction of cervical radiology. Scand J Rheumatology 16:355-359, 1987

P.269 掲載の参考文献

• 1) Lynch MA, Henning CE:Osteoarthritis and the ACL-deficient knee:the crucial ligaments:diagnosis and treatment of ligamentous injuries about the knee. In (Ed, Feagin JA), pp.385-391, New York, NY, Churchill Livingstone, 1988

• 2) 広瀬一史, 史野根生, 土井照夫, ほか:陳旧性前十字靭帯損傷膝におけるレ線学的変化. 臨整外 20:943-947, 1985

• 3) 堀部秀二, 史野根生, 井上雅裕, ほか:前十字靭帯損傷膝に伴う半月板損傷の検討. 整形外科 39:875-881, 1988

• 4) 中嶋寛之, 黒沢 尚, 福林 徹, ほか:女子体操選手における前十字靭帯損傷. 整・災外 27:609-612, 1984

• 5) 増島 篤, 中嶋寛之, 入江一憲, ほか:女性のスポーツ外傷・障害に関する研究第2報. 昭和61年度日本体育協会スポーツ科学研究報告, 1986